ARS Pharmaceuticals, Inc. — All Filings
494 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B4
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFM14A
DRS
EFFECT
PREM14A
PRER14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 SUBMISSION | 0001209191-20-062048 | Dec 7, 2020 | Dec 3, 2020 |
| 4 | FORM 4 SUBMISSION | 0001209191-20-062047 | Dec 7, 2020 | Dec 3, 2020 |
| S-8 | S-8 | 0001193125-20-310624 | Dec 4, 2020 | — |
| 424B4 | 424B4 | 0001193125-20-310601 | Dec 4, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-20-061718 | Dec 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-20-061717 | Dec 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-20-061716 | Dec 3, 2020 | — |
| SEC STAFF LETTER | — | 9999999997-20-005593 | Dec 3, 2020 | — |
| CERT | — | 0001354457-20-000745 | Dec 3, 2020 | — |
| S-1/A | S-1/A | 0001193125-20-308867 | Dec 3, 2020 | — |
| EFFECT | — | 9999999995-20-003391 | Dec 3, 2020 | — |
| S-1MEF | S-1MEF | 0001193125-20-309828 | Dec 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-20-061735 | Dec 3, 2020 | — |
| 3 | FORM 3 | 0001722024-20-000018 | Dec 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-20-061733 | Dec 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-20-061732 | Dec 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-20-061731 | Dec 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-20-061730 | Dec 3, 2020 | — |
| 3 | PRIMARY DOCUMENT | 0001548538-20-000024 | Dec 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-20-061726 | Dec 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-20-061724 | Dec 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-20-061722 | Dec 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-20-061721 | Dec 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-20-061719 | Dec 3, 2020 | — |
| CORRESP | — | 0001193125-20-307211 | Dec 1, 2020 | — |
| 8-A12B | 8-A12B | 0001193125-20-307168 | Dec 1, 2020 | — |
| CORRESP | — | 0001193125-20-307229 | Dec 1, 2020 | — |
| S-1/A | S-1/A | 0001193125-20-304858 | Nov 30, 2020 | — |
| CORRESP | — | 0001193125-20-304864 | Nov 30, 2020 | — |
| UPLOAD | — | 0000000000-20-011363 | Nov 27, 2020 | — |
| CORRESP | — | 0001193125-20-296478 | Nov 18, 2020 | — |
| S-1 | S-1 | 0001193125-20-290236 | Nov 10, 2020 | — |
| CORRESP | — | 0001193125-20-290247 | Nov 10, 2020 | — |
| SEC STAFF LETTER | — | 9999999997-20-005201 | Oct 30, 2020 | — |
| UPLOAD | — | 0000000000-20-010245 | Oct 29, 2020 | — |
| D | — | 0001671858-20-000002 | Oct 6, 2020 | — |
| DRS | — | 0000950123-20-010063 | Oct 2, 2020 | — |
| D | — | 0001671858-20-000001 | Mar 19, 2020 | — |
| D | — | 0001671858-18-000002 | Sep 20, 2018 | — |
| D | — | 0001671858-18-000001 | Jan 8, 2018 | — |
| D/A | — | 0001671858-17-000002 | Feb 6, 2017 | — |
| D | — | 0001671858-16-000003 | Nov 30, 2016 | — |
| D | — | 0001671858-16-000001 | Apr 12, 2016 | — |
| D | — | 0001671858-16-000002 | Apr 12, 2016 | — |